Radcliffe Capital Management’s Prenetics Global Ltd Warrant PRENW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-553,324
Closed -$4.56K – 46
2024
Q1
$4.56K Sell
553,324
-98,742
-15% -$790 ﹤0.01% 73
2023
Q4
$5.31K Sell
652,066
-15,950
-2% -$241 ﹤0.01% 146
2023
Q3
$31.3K Sell
668,016
-158,273
-19% -$9.26K ﹤0.01% 229
2023
Q2
$55.2K Hold
826,289
– – ﹤0.01% 253
2023
Q1
$72.3K Hold
826,289
– – ﹤0.01% 308
2022
Q4
$1.65M Hold
826,289
– – 0.05% 532
2022
Q3
$3.12M Hold
826,289
– – 0.08% 442
2022
Q2
$3.34M Buy
+826,289
New +$308K 0.08% 451

Other funds holding PRENW

Radcliffe Capital Management's PRENW Position: Q2 2024 in Review

Radcliffe Capital Management sold out of Prenetics Global Ltd Warrant (PRENW) in Q2 2024, closing a stake of 553,324 shares — an estimated $4.56K sold.

Radcliffe Capital Management first reported a position in PRENW in Q2 2022 and held it in 8 quarters. The position peaked at $3.34M in Q2 2022. 21 funds tracked by Wall St. Rank hold PRENW as of Q2 2024.

  • Radcliffe Capital Management reported no remaining Prenetics Global Ltd Warrant position as of Q2 2024 after selling out during the quarter.
  • Radcliffe Capital Management sold 553,324 Prenetics Global Ltd Warrant shares in Q2 2024, an estimated $4.56K.
  • Radcliffe Capital Management first reported a position in Prenetics Global Ltd Warrant in Q2 2022 and held it in 8 quarters.
  • Radcliffe Capital Management's Prenetics Global Ltd Warrant position peaked at $3.34M in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Prenetics Global Ltd Warrant as of Q2 2024.

Based on Radcliffe Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.